Table 1.
Baseline characteristics of the study participants by treatment group
| HP group (n = 27) | NP group (n = 27) | p valuea | |
|---|---|---|---|
| Age, years | 59.0±6 | 58.7±6 | 0.566 |
| PAL | 1.4±0.1 | 1.4±0.1 | 0.377 |
| Body weight, kg | 85.1±8.6 | 84.9±9.8 | 0.929 |
| BMI | 30.5±2.8 | 31.3±4.0 | 0.439 |
| FFM, kg | 46.8±6.9 | 46.7±5.0 | 0.940 |
| Fat mass, kg | 38.3±5.6 | 38.2±6.9 | 0.947 |
| Waist circumference, cm | 98.2±6.9 | 98.4±10.8 | 0.878 |
| REE, kJ (kcal) | 7,174±707 | 7,082±837 | |
| (1,714±169) | (1,692±200) | 0.665 | |
| SPPB score | 9.4±1.1 | 9.9±1.0 | 0.119 |
| Handgrip strength, kg | 28.7±7.2 | 29.0±4.9 | 0.652 |
| 400-m walk, min:s | 4:10±0:33 | 04:11±0:31 | 0.692 |
| Urea, mg/dL | 33.2±7.6 | 27.5±5.6 | 0.003 |
Data are presented as means ± SD.
a
Significance level for an independent t test.